Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 113

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation

Bochner, Bruce S., Zimmermann, Nives · 2015 · Journal of Allergy and Clinical Immunology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2014.11.031

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 101

  1. Lepenies, 2013, Targeting C-type lectin receptors with multivalent carbohydrate ligands, Adv Drug Deliv Rev, 65, 1271, 10.1016/j.addr.2013.05.007 · DOI · Paper page
  2. Powlesland, 2010, Engineered carbohydrate-recognition domains for glycoproteomic analysis of cell surface glycosylation and ligands for glycan-binding receptors, Methods Enzymol, 480, 165, 10.1016/S0076-6879(10)80009-6 · doi:10.1016/s0076-6879(10)80009-6
  3. Rabinovich, 2012, Glycobiology of immune responses, Ann N Y Acad Sci, 1253, 1, 10.1111/j.1749-6632.2012.06492.x · DOI · Paper page
  4. Stowell, 2014, Microbial glycan microarrays define key features of host-microbial interactions, Nat Chem Biol, 10, 470, 10.1038/nchembio.1525 · DOI · Paper page
  5. Varki, 2012, Multifarious roles of sialic acids in immunity, Ann N Y Acad Sci, 1253, 16, 10.1111/j.1749-6632.2012.06517.x · DOI · Paper page
  6. Varki, 2007, Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins, Nature, 446, 1023, 10.1038/nature05816 · DOI · Paper page
  7. Varki, 2006, Siglecs—the major sub-family of I-type lectins, Glycobiology, 16, 1R, 10.1093/glycob/cwj008 · DOI · Paper page
  8. Crocker, 2007, Siglecs and their roles in the immune system, Nat Rev Immunol, 7, 255, 10.1038/nri2056 · DOI · Paper page
  9. von Gunten, 2008, Basic and clinical immunology of Siglecs, Ann N Y Acad Sci, 1143, 61, 10.1196/annals.1443.011 · DOI · Paper page
  10. Pillai, 2012, Siglecs and immune regulation, Annu Rev Immunol, 30, 357, 10.1146/annurev-immunol-020711-075018 · DOI · Paper page
  11. Paulson, 2012, Siglecs as sensors of self in innate and adaptive immune responses, Ann N Y Acad Sci, 1253, 37, 10.1111/j.1749-6632.2011.06362.x · DOI
  12. Crocker, 2012, CD33-related siglecs as potential modulators of inflammatory responses, Ann N Y Acad Sci, 1253, 102, 10.1111/j.1749-6632.2011.06449.x · DOI
  13. Schnaar, 2015, Glycans and glycan binding proteins in immune regulation: a concise introduction to glycobiology for the allergist, J Allergy Clin Immunol, 135, 609, 10.1016/j.jaci.2014.10.057 · DOI
  14. Bochner, 2005, Glycan array screening reveals a candidate ligand for Siglec-8, J Biol Chem, 280, 4307, 10.1074/jbc.M412378200 · DOI · Paper page
  15. Kiwamoto, 2014, Mice deficient in the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation, J Allergy Clin Immunol, 133, 240, 10.1016/j.jaci.2013.05.018 · DOI
  16. Tateno, 2005, Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6′-sulfo-sialyl Lewis X as a preferred glycan ligand, Glycobiology, 15, 1125, 10.1093/glycob/cwi097 · DOI · Paper page
  17. Bochner, 2009, Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors, Clin Exp Allergy, 39, 317, 10.1111/j.1365-2222.2008.03173.x · DOI · Paper page
  18. Zhang, 2004, The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils, Eur J Immunol, 34, 1175, 10.1002/eji.200324723 · DOI · Paper page
  19. Kano, 2013, Mechanism of Siglec-8-mediated cell death in IL-5-activated eosinophils: role for reactive oxygen species-enhanced MEK/ERK activation, J Allergy Clin Immunol, 132, 437, 10.1016/j.jaci.2013.03.024 · DOI
  20. Nutku, 2003, Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis, Blood, 101, 5014, 10.1182/blood-2002-10-3058 · DOI · Paper page
  21. Nutku, 2005, Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury, Biochem Biophys Res Commun, 336, 918, 10.1016/j.bbrc.2005.08.202 · DOI
  22. Nutku-Bilir, 2008, Interleukin-5 priming of human eosinophils alters Siglec-8 mediated apoptosis pathways, Am J Respir Cell Mol Biol, 38, 121, 10.1165/rcmb.2007-0154OC · DOI
  23. von Gunten, 2005, Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment, Blood, 106, 1423, 10.1182/blood-2004-10-4112 · DOI · Paper page
  24. Rashmi, 2009, Siglec-9 and SHP-1 are differentially expressed in neonatal and adult neutrophils, Pediatr Res, 66, 266, 10.1203/PDR.0b013e3181b1bc19 · DOI
  25. McMillan, 2014, Siglec-E promotes β2-integrin-dependent NADPH oxidase activation to suppress neutrophil recruitment to the lung, J Biol Chem, 289, 20370, 10.1074/jbc.M114.574624 · DOI
  26. Yokoi, 2008, Inhibition of FcεRI-dependent mediator release and calcium flux from human mast cells by Siglec-8 engagement, J Allergy Clin Immunol, 121, 499, 10.1016/j.jaci.2007.10.004 · DOI
  27. Mao, 2013, Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygen, PLoS One, 8, e68143, 10.1371/journal.pone.0068143 · DOI
  28. Avril, 2004, The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells, J Immunol, 173, 6841, 10.4049/jimmunol.173.11.6841 · DOI · Paper page
  29. Varchetta, 2012, Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes, PLoS One, 7, e45821, 10.1371/journal.pone.0045821 · DOI
  30. Kiwamoto, 2012, Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions, Pharmacol Ther, 135, 327, 10.1016/j.pharmthera.2012.06.005 · DOI · Paper page
  31. von Gunten, 2009, Different patterns of Siglec-9-mediated neutrophil death responses in septic shock, Shock, 32, 386, 10.1097/SHK.0b013e3181a1bc98 · doi:10.1097/shk.0b013e3181a1bc98
  32. Hudson, 2009, Eosinophil-selective binding and pro-apoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6′-sulfated sialyl Lewis X, J Pharmacol Exp Ther, 330, 608, 10.1124/jpet.109.152439 · DOI
  33. Guo, 2011, Characterization of expression of glycan ligands for Siglec-F in normal mouse lungs, Am J Respir Cell Mol Biol, 44, 238, 10.1165/rcmb.2010-0007OC · DOI
  34. Patnode, 2013, Galactose 6-O-sulfotransferases are not required for the generation of Siglec-F ligands in leukocytes or lung tissue, J Biol Chem, 288, 26533, 10.1074/jbc.M113.485409 · DOI
  35. Kiwamoto, 2014, Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis, J Allergy Clin Immunol, 10.1016/j.jaci.2013.12.579 · doi:10.1016/j.jaci.2013.12.579
  36. Zarbock, 2011, Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow, Blood, 118, 6743, 10.1182/blood-2011-07-343566 · DOI · Paper page
  37. McEver, 2010, Rolling cell adhesion, Annu Rev Cell Dev Biol, 26, 363, 10.1146/annurev.cellbio.042308.113238 · DOI · Paper page
  38. Bochner, 2000, Road signs guiding leukocytes along the inflammation superhighway, J Allergy Clin Immunol, 106, 817, 10.1067/mai.2000.110813 · DOI
  39. Sandrin, 1995, Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis, Nat Med, 1, 1261, 10.1038/nm1295-1261 · DOI · Paper page
  40. Steinke, 2015, The alpha gal story: lessons learned from connecting the dots, J Allergy Clin Immunol, 135, 589, 10.1016/j.jaci.2014.12.1947 · DOI · Paper page
  41. Oliveira, 2010, Laboratory evaluation of primary immunodeficiencies, J Allergy Clin Immunol, 125, S297, 10.1016/j.jaci.2009.08.043 · DOI
  42. von Gunten, 2009, Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass, J Allergy Clin Immunol, 123, 1268, 10.1016/j.jaci.2009.03.013 · DOI
  43. Dalziel, 2014, Emerging principles for the therapeutic exploitation of glycosylation, Science, 343, 1235681, 10.1126/science.1235681 · DOI · Paper page
  44. Prasanphanich, 2014, Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite, Glycobiology, 24, 619, 10.1093/glycob/cwu027 · DOI
  45. Scanlan, 2007, Exploiting the defensive sugars of HIV-1 for drug and vaccine design, Nature, 446, 1038, 10.1038/nature05818 · DOI · Paper page
  46. Webster, 2014, Continuing challenges in influenza, Ann N Y Acad Sci, 1323, 115, 10.1111/nyas.12462 · DOI · Paper page
  47. Rempel, 2008, Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity, PLoS One, 3, e1967, 10.1371/journal.pone.0001967 · DOI · Paper page
  48. van der Kuyl, 2007, Sialoadhesin (CD169) expression in CD14+ cells is upregulated early after HIV-1 infection and increases during disease progression, PLoS One, 2, e257, 10.1371/journal.pone.0000257 · DOI
  49. Puryear, 2012, HIV-1 incorporation of host-cell-derived glycosphingolipid GM3 allows for capture by mature dendritic cells, Proc Natl Acad Sci U S A, 109, 7475, 10.1073/pnas.1201104109 · DOI
  50. Kardava, 2011, Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors, J Clin Invest, 121, 2614, 10.1172/JCI45685 · DOI
  51. Chen, 2013, Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation, Cell, 152, 467, 10.1016/j.cell.2013.01.011 · DOI · Paper page
  52. Varki, 2010, Colloquium paper: uniquely human evolution of sialic acid genetics and biology, Proc Natl Acad Sci U S A, 107, 8939, 10.1073/pnas.0914634107 · DOI · Paper page
  53. Chang, 2014, The interplay between Siglecs and sialylated pathogens, Glycobiology, 24, 818, 10.1093/glycob/cwu067 · DOI
  54. Angata, 2013, Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation, Cell Mol Life Sci, 70, 3199, 10.1007/s00018-013-1311-7 · DOI
  55. Ali, 2014, Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus, J Exp Med, 211, 1231, 10.1084/jem.20131853 · DOI · Paper page
  56. Chen, 2014, Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1, Elife, 3, e04066, 10.7554/eLife.04066 · DOI
  57. Etzioni, 2000, Leukocyte adhesion deficiency II-from A to almost Z, Immunol Rev, 178, 138, 10.1034/j.1600-065X.2000.17805.x · DOI
  58. van de Vijver, 2012, Hematologically important mutations: leukocyte adhesion deficiency (first update), Blood Cells Mol Dis, 48, 53, 10.1016/j.bcmd.2011.10.004 · DOI · Paper page
  59. Arnold, 2007, The impact of glycosylation on the biological function and structure of human immunoglobulins, Annu Rev Immunol, 25, 21, 10.1146/annurev.immunol.25.022106.141702 · DOI · Paper page
  60. Schwab, 2013, Intravenous immunoglobulin therapy: how does IgG modulate the immune system?, Nat Rev Immunol, 13, 176, 10.1038/nri3401 · DOI · Paper page
  61. von Gunten, 2014, IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist, Nat Rev Immunol, 14, 349, 10.1038/nri3401-c1 · DOI
  62. Samuelsson, 2001, Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor, Science, 291, 484, 10.1126/science.291.5503.484 · DOI · Paper page
  63. Anthony, 2008, Identification of a receptor required for the anti-inflammatory activity of IVIG, Proc Natl Acad Sci U S A, 105, 19571, 10.1073/pnas.0810163105 · DOI · Paper page
  64. Masuda, 2007, Enhanced binding affinity for FcγRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity, Mol Immunol, 44, 3122, 10.1016/j.molimm.2007.02.005 · DOI · Paper page
  65. Chung, 2014, Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies—impact of effector cells, J Immunol Methods, 407, 63, 10.1016/j.jim.2014.03.021 · DOI
  66. Kolbeck, 2010, MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function, J Allergy Clin Immunol, 125, 1344, 10.1016/j.jaci.2010.04.004 · DOI · Paper page
  67. Jandus, 2014, Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance, J Clin Invest, 124, 1810, 10.1172/JCI65899 · DOI · Paper page
  68. Hudak, 2014, Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion, Nat Chem Biol, 10, 69, 10.1038/nchembio.1388 · DOI · Paper page
  69. Kimura, 2013, MUC1 immunotherapy is here to stay, Expert Opin Biol Ther, 13, 35, 10.1517/14712598.2012.725719 · DOI
  70. Mizrahi, 2014, Siglec-7 is an inhibitory receptor on human mast cells and basophils, J Allergy Clin Immunol, 134, 230, 10.1016/j.jaci.2014.03.031 · DOI
  71. Zimmermann, 2008, Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils, Allergy, 63, 1156, 10.1111/j.1398-9995.2008.01709.x · DOI
  72. Song, 2009, Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling, J Immunol, 183, 5333, 10.4049/jimmunol.0801421 · DOI
  73. Rubinstein, 2011, Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis, J Pediatr Gastroenterol Nutr, 53, 409, 10.1097/MPG.0b013e3182182ff8 · DOI
  74. Song, 2009, Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse model, Clin Immunol, 131, 157, 10.1016/j.clim.2008.11.009 · doi:10.1016/j.clim.2008.11.009
  75. Zhang, 2007, Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils, Blood, 109, 4280, 10.1182/blood-2006-08-039255 · DOI · Paper page
  76. Cho, 2010, Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13, Respir Res, 11, 154, 10.1186/1465-9921-11-154 · DOI
  77. Suzukawa, 2013, Sialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in mice, J Immunol, 190, 5939, 10.4049/jimmunol.1203455 · DOI
  78. Kiwamoto, 2013, The role of lung epithelial ligands for Siglec-8 and Siglec-F in eosinophilic inflammation, Curr Opin Allergy Clin Immunol, 13, 106, 10.1097/ACI.0b013e32835b594a · DOI
  79. Muller, 2014, The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease, Nat Rev Rheumatol, 10, 422, 10.1038/nrrheum.2014.54 · DOI
  80. Hoffmann, 2007, Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population, Nat Immunol, 8, 695, 10.1038/ni1480 · DOI · Paper page
  81. Bokers, 2014, Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice, J Immunol, 192, 2994, 10.4049/jimmunol.1303367 · DOI
  82. Toubai, 2014, Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice, Blood, 123, 3512, 10.1182/blood-2013-12-545335 · DOI
  83. Jellusova, 2010, CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity, J Immunol, 184, 3618, 10.4049/jimmunol.0902711 · DOI
  84. Bandala-Sanchez, 2013, T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10, Nat Immunol, 14, 741, 10.1038/ni.2610 · DOI · Paper page
  85. Grader-Beck, 2011, Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease, Ann Rheum Dis, 70, 2218, 10.1136/ard.2011.153130 · DOI
  86. Dotan, 2006, Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease, Gastroenterology, 131, 366, 10.1053/j.gastro.2006.04.030 · DOI · Paper page
  87. Dotan, 2006, Anti-glycan antibodies as biomarkers for diagnosis and prognosis, Lupus, 15, 442, 10.1191/0961203306lu2331oa · DOI
  88. Rillahan, 2012, Click and pick: identification of sialoside analogues for siglec-based cell targeting, Angew Chem Int Ed Engl, 51, 11014, 10.1002/anie.201205831 · DOI
  89. Nycholat, 2012, In silico-aided design of a glycan ligand of sialoadhesin for in vivo targeting of macrophages, J Am Chem Soc, 134, 15696, 10.1021/ja307501e · DOI
  90. Rillahan, 2014, Disubstituted sialic acid ligands targeting Siglecs CD33 and CD22 associated with myeloid leukaemias and B cell lymphomas, Chem Sci, 5, 2398, 10.1039/c4sc00451e · DOI
  91. O'Reilly, 2009, Siglecs as targets for therapy in immune-cell-mediated disease, Trends Pharmacol Sci, 30, 240, 10.1016/j.tips.2009.02.005 · DOI · Paper page
  92. Kawasaki, 2013, Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation, Proc Natl Acad Sci U S A, 110, 7826, 10.1073/pnas.1219888110 · DOI
  93. Kawasaki, 2014, Targeted delivery of mycobacterial antigens to human dendritic cells via Siglec-7 induces robust T cell activation, J Immunol, 193, 1560, 10.4049/jimmunol.1303278 · DOI
  94. Duong, 2010, Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo, J Exp Med, 207, 173, 10.1084/jem.20091873 · DOI · Paper page
  95. Macauley, 2013, Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis, J Clin Invest, 123, 3074, 10.1172/JCI69187 · DOI · Paper page
  96. Pfrengle, 2013, Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22, J Immunol, 191, 1724, 10.4049/jimmunol.1300921 · DOI
  97. von Gunten, 2006, Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations, Blood, 108, 4255, 10.1182/blood-2006-05-021568 · DOI
  98. von Gunten, 2007, Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies, J Allergy Clin Immunol, 119, 1005, 10.1016/j.jaci.2007.01.023 · DOI
  99. Collin, 2008, IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions, Proc Natl Acad Sci U S A, 105, 4265, 10.1073/pnas.0711271105 · DOI
  100. Lood, 2012, IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment?, Arthritis Rheum, 64, 2698, 10.1002/art.34454 · DOI
  101. Nandakumar, 2013, Dominant suppression of inflammation by glycan-hydrolyzed IgG, Proc Natl Acad Sci U S A, 110, 10252, 10.1073/pnas.1301480110 · DOI

Cited by

See all 113

Metadata

Authors
Bochner, B. S., & Zimmermann, N.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2015-03
Volume
135
Issue
3
Pages
598-608
ISSN
0091-6749
Cited by
113
References
13
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • National Institutes of Health (R01 AI072265, P01 HL107151)
  • Johns Hopkins University (SRA 130701, R21 AI103853)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.